02/09/23 9:15 AMNasdaq : AEHAU, AEHA, AEHAW acquisitionOcean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer TypesMultiple Patents granted for Methods and Composition for Mono-specific and Bi-specific antibody approaches that suppress tumors by targeting and neutralizing elevated levels of chitinase 3-like-1 ( CH I 3L1 ) and other mediators . Ocean Biomedical is expected to become a publicly traded company onRHEA-AIpositive
02/06/23 9:15 AMNasdaq : AEHAU, AEHA, AEHAW Aesther and Ocean Biomedical Announce Shareholder Approval of Business CombinationAesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company, today announced that its stockholders approvedRHEA-AIneutral
02/01/23 5:43 PMNasdaq : AEHAU, AEHA, AEHAW acquisitionAesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise TaxAesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company announced today that AEHA has filed with the U.S.RHEA-AIneutral
01/30/23 9:15 AMNasdaq : AEHAU, AEHA, AEHAW acquisitionOcean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other CancersResults outline novel bispecific antibody approach that generates strong anti-tumor response in malignant melanoma, holding potential to control important pathways in multiple cancer types Ocean Biomedical is expected to become a publicly traded company on the NASDAQ global market under the symbolsRHEA-AIneutral
01/24/23 9:15 AMNasdaq : AEHAU, AEHA, AEHAW Ocean Biomedical Provides Corporate Update and Company SummaryOcean Biomedical (“Ocean”), a next-generation biopharma company, and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA), a publiclyRHEA-AIneutral
01/13/23 5:05 PMNasdaq : AEHAU, AEHA, AEHAW acquisitionAesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company announced today that AEHA has filed with the U.S.RHEA-AIneutral
12/16/22 8:30 AMNasdaq : AEHAU, AEHA, AEHAW acquisitionAesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business CombinationAs previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into definitive merger agreement with Ocean Biomedical, Inc. Aesther announced today that it has paid, and thatRHEA-AIneutral
12/13/22 9:15 AMNasdaq : AEHAU, AEHA, AEHAW acquisitionAesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business CombinationAs previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into definitive merger agreement with Ocean Biomedical, Inc. Aesther announced today that its Board of DirectorsRHEA-AIneutral
11/01/22 9:15 AMNasdaq : AEHAU, AEHA, AEHAW Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs.Ocean Biomedical andRHEA-AIneutral
10/05/22 7:45 AMNasdaq : AEHAU, AEHA, AEHAW acquisitionAesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 MillionAesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical, Inc. (“Ocean”), a next-generation biopharma company announced today that Aesther has entered intoRHEA-AIneutral
